You have 9 free searches left this month | for more free features.

pasireotide LAR

Showing 1 - 25 of 188

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Neuroendocrine Tumors, Carcinoid Tumors Trial in Stanford, Tampa (Pasireotide Long Acting Release (LAR))

Active, not recruiting
  • Neuroendocrine Tumors
  • Carcinoid Tumors
  • Pasireotide Long Acting Release (LAR)
  • Stanford, California
  • +1 more
Jan 11, 2022

Pituitary Tumor, ACTH-producing Pituitary Tumour Trial in New York (Pasireotide LAR)

Terminated
  • Pituitary Tumor
  • ACTH-producing Pituitary Tumour
  • Pasireotide LAR
  • New York, New York
    Neuroendocrine Unit and Pituitary Center, Columbia University
Mar 31, 2021

Enterostomy Trial in France (Pasireotide, Placebo)

Completed
  • Enterostomy
  • Amiens, France
  • +13 more
Mar 23, 2022

Gastroenteropancreatic Neuroendocrine Tumor of the Pulmonary ot Gastroenteropancreatic System Trial in Germany (Pasireotide LAR

Completed
  • Gastroenteropancreatic Neuroendocrine Tumor of the Pulmonary ot Gastroenteropancreatic System
  • Pasireotide LAR followed by Pasireotide LAR + Everolimus
  • Everolimus followed by Pasireotide LAR + Everolimus
  • Bad Berka, Germany
  • +3 more
Dec 17, 2020

Castration Resistant Prostate Cancer Trial in Germany (SOM230)

Completed
  • Castration Resistant Prostate Cancer
  • Berlin, Germany
  • +3 more
Dec 17, 2020

Metastatic Melanoma and Merkel Cell Carcinoma Trial in Essen, Lausanne, Zuerich (Pasireotide sub-cutaneous formulation,

Completed
  • Metastatic Melanoma and Merkel Cell Carcinoma
  • Pasireotide sub-cutaneous formulation
  • Pasireotide lon acting release formulation
  • Essen, Germany
  • +2 more
Dec 17, 2020

Neuroendocrine Carcinoma of the Lung and Thymus Trial in Worldwide (Pasireotide LAR, Everolimus, Pasireotide LAR and Everolimus

Completed
  • Neuroendocrine Carcinoma of the Lung and Thymus
  • Pasireotide LAR
  • +2 more
  • Aarhus, Denmark
  • +35 more
Mar 8, 2021

Neuroendocrine Tumors Trial in United States (Pasireotide LAR)

Completed
  • Neuroendocrine Tumors
  • Pasireotide LAR
  • Los Angeles, California
  • +3 more
Dec 17, 2020

Somatostatin Analogs, Polycystic Liver Disease, Autosomal Dominant Polycystic Kidney Disease Trial in Rochester (Pasireotide

Completed
  • Somatostatin Analogs
  • +3 more
  • Pasireotide LAR
  • Placebo
  • Rochester, Minnesota
    Mayo Clinic
Apr 30, 2020

Carcinoid Tumor, Acromegaly Trial in Worldwide (Pasireotide)

Completed
  • Carcinoid Tumor
  • Acromegaly
  • Los Angeles, California
  • +16 more
Dec 17, 2020

Pancreatic Cancer Trial in Tampa (SOM 230 LAR, Gemcitabine)

Completed
  • Pancreatic Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Sep 25, 2020

Cushing's Disease, Acromegaly, Neuroendocrine Tumors Trial in Worldwide (Pasireotide, Cabergoline)

Active, not recruiting
  • Cushing's Disease
  • +8 more
  • La Jolla, California
  • +93 more
May 19, 2022

Acromegaly, Pituitary Gigantism Trial in Japan (Pasireotide LAR)

Completed
  • Acromegaly
  • Pituitary Gigantism
  • Pasireotide LAR
  • Nagoya, Aichi, Japan
  • +26 more
Aug 12, 2019

Non-functioning Pituitary Adenoma Trial in Brazil (Pasireotide LAR)

Completed
  • Non-functioning Pituitary Adenoma
  • Pasireotide LAR
  • Fortaleza, CE, Brazil
  • +6 more
Apr 24, 2019

Neuroendocrine Tumors Trial in Bad Berka, Berlin, Muenster (RAD001, SOM230)

Completed
  • Neuroendocrine Tumors
  • Bad Berka, Germany
  • +2 more
Apr 13, 2019

Acromegaly Trial in Worldwide (Pasireotide LAR)

Completed
  • Acromegaly
  • Pasireotide LAR
  • Caba, Buenos Aires, Argentina
  • +49 more
Dec 6, 2019

Cushing Disease Trial in France (Patient group, Remission control group, Bilateral surrenalectomy control group)

Recruiting
  • Cushing Disease
  • Patient group
  • +2 more
  • Caen, France
  • +6 more
Dec 16, 2021

Cushing's Disease, Acromegaly Trial in Worldwide (Pasireotide s.c., Sitagliptin, Liraglutide)

Completed
  • Cushing's Disease
  • Acromegaly
  • Pasireotide s.c.
  • +5 more
  • Multiple Locations, California
  • +42 more
May 7, 2019

Somatostatin Receptors and GH Receptor Expression on Bone of

Completed
  • Evaluation of the Expression of Somatostatin Receptors and GH Receptor on Bone of Acromegalic Patients
  • Trans-sphenoidal surgery
  • Roma, Italy
    Fondazione Policlinnico Gemelli IRCCS
Apr 6, 2023

Colorectal Cancer, Stoma Ileostomy Trial (Diverting loop ileostomy)

Not yet recruiting
  • Colorectal Cancer
  • Stoma Ileostomy
  • Diverting loop ileostomy
  • (no location specified)
Nov 21, 2023

Pasireotide s.c. in Patients With Cushing's Disease

Recruiting
  • Cushings Disease
  • Phoenix, Arizona
  • +70 more
May 19, 2022

Gastro-enteropancreatic Neuroendocrine Tumor Trial (Pasireotide, Diazoxide)

Withdrawn
  • Gastro-enteropancreatic Neuroendocrine Tumor
  • (no location specified)
Feb 17, 2022

Low Anterior Resection Syndrome in Newly Diagnosed Rectal

Recruiting
  • Rectal Cancer
    • Taoyuan City, Kwei-Shan Dist., Taiwan
      Chung Gung University
    Jun 30, 2022

    Triple-Negative Breast Cancer Trial in Shanghai (Trastuzumab Deruxtecan)

    Not yet recruiting
    • Triple-Negative Breast Cancer
    • Trastuzumab Deruxtecan
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Jul 12, 2023